Professional Documents
Culture Documents
Therapeutics and
Prescribing
2014-15 Edition
Describe the mechanism of action and clinical use of [the drug/class of drug]
Describe any major pharmacokinetic characteristics which affect the clinical use
of [the drug/class of drug]
Phase II outcomes
Essential drugs (shown in CAPITALS in the formulary)
Some drugs are used under specialist supervision only and are highlighted in ITALICS.
They are included because they may demonstrate a novel mechanism of action or may
have important adverse reactions or interactions that you should be aware of and be
able to recognise.
A student who achieves these targets should be able to cope effectively and safely
with most of the prescribing challenges that they will face in their early postgraduate
years whether in hospital or in general practice.
BNF Section 1
1.1
1.2
1.3
1.4
1.5
1.6
MAIN DRUGS
Aluminium hydroxide
Hyoscine butylbromide
Mebeverine
Motility Stimulant
H2-receptor Antagonists
Metoclopramide
RANITIDINE
OMEPRAZOLE
Loperamide
Mesalazine
Cytokine modulators
Bulk-forming drugs
Stimulant Laxatives
Infliximab
ISPAGHULA HUSK
SENNA
Sodium docusate
Osmotic Laxatives
Lactulose
Macrogols
Antacids
ALTERNATIVES
LANSOPRAZOLE
BNF Section 2
2.1
2.2
2.3
Anti-arrhythmic Drugs
2.4
2.5
Antihypertensive Therapy
2.6
Cardiac glycosides
Thiazides
Loop diuretics
Potassium sparing diuretics
Aldosterone Antagonist
Drugs for arrhythmias
Alpha-adrenoceptor antagonists
ACE inhibitors
Angiotensin II antagonists
Centrally acting antihypertensives
Nitrates
Calcium Channel Blockers
2.7
Sympathomimetics
2.8
Anticoagulants
MAIN DRUGS
DIGOXIN
BENDROFLUMETHIAZIDE
FUROSEMIDE
Amiloride
SPIRONOLACTONE
ATROPINE
ADENOSINE
AMIODARONE
Flecainide
BISOPROLOL
Doxazosin
LISINOPRIL
Losartan
Methyldopa
GLYCERYL TRINITRATE
ISOSORBIDE MONONITRATE
AMLODIPINE
Diltiazem
Verapamil
Nicorandil
Norepinephrine
EPINEPHRINE
Heparin (unfractionated)
ENOXAPARIN
WARFARIN
ALTERNATIVES
Atenolol
Propranolol
RAMIPRIL
NIFEDIPINE
Tinzaparin
2.9
Antiplatelet Drugs
2.10
2.11
Fibrinolytic Drugs
Antifibrinolytic drugs and
Haemostatics
2.12
Lipid-regulating drugs
Blood-related products
Dabigatran
ASPIRIN
CLOPIDOGREL
ALTEPLASE (rt-PA)
Dried Prothrombin Complex
ATORVASTATIN
BNF Section 3
3.1
Bronchodilators
3.3
Inhaled Corticosteroids
3.3
3.4
Selective 2 Adrenoreceptor
Stimulants
Antimuscarinic Bronchodilators
Oxygen
3.7
Mucolytics
ALTERNATIVES
IPATROPIUM BROMIDE
Tiotropium
Xanthines
Theophylline
Aminophylline
CHLORPHENAMINE
3.6
MAIN DRUGS
SALBUTAMOL
Salmeterol
EPINEPHRINE
Hydrocortisone
OXYGEN
Oxygen concentrator
Carbocisteine
BNF Section 4
4.1
4.2
Antipsychotic drugs
Related Disorders
Antimanic drugs
4.3
Antidepressant Drugs
4.7
Analgesics
Antihistamines
Phenothiazines and related drugs
5-HT3 receptor antagonists
Non-opioid analgesics and compound
analgesic preparations
MAIN DRUGS
DIAZEPAM
Lorazepam
Zopcilone
HALOPERIDOL
(oral, im, depot)
OLANZAPINE
Risperidone
Quetiapine
Clozapine
LITHIUM
Valproic acid
AMITRIPTYLINE
Phenelzine
FLUOXETINE
Sertraline
Citalopram
Mirtazapine
Venlafaxine
CYCLIZINE
PROCHLORPERAZINE
METOCLOPRAMIDE
Ondansetron
ASPIRIN
PARACETAMOL
NAPROXEN
ALTERNATIVES
TEMAZEPAM
CHLORDIAZEPOXIDE
Aripiprazole
Amisulpiride
Lamotrigine
Trazodone
DOMPERIDONE
IBUPROFEN
Diclofenac
Opioid Analgesics
4.8
Antiepileptics (anticonvulsants)
Neuropathic pain
Antimigraine drugs
Control of the epilepsies
4.10
4.11
Dopaminergic drugs
Antimuscarinics
Nicotine dependence
Opioid dependence
CODEINE
MORPHINE
Tramadol
Gabapentin
Sumatriptan
CARBAMAZEPINE
PHENYTOIN
SODIUM VALPROATE
Lamotrigine
DIAZEPAM
PHENYTOIN
CO-CARELDOPA
Bromocriptine
Selegiline
Entacapone
Apomorphine
Procyclidine
NICOTINE
Methadone
Donepezil
Rivastigmine
Galantamine
Memantine
DIAMORPHINE
Amitriptyline
LORAZEPAM
BNF Section 5
5.1
Antibacterial drugs
Penicillins
Cephalosporins, cephamycins
and other
Carbapenems
Tetracyclines
Aminoglycosides
Macrolides
Sulfonamides and trimethoprim
Anti-tuberculosis drugs
5.2
Antifungal Drugs
Triazole antifungals
Other antifungals
ALTERNATIVES
BENZYLPENICILLIN
AMOXICILLIN
FLUCLOXACILLIN
Co-amoxiclav
Piperacillin with tazobactam
Cefalexin
Cefotaxime
Meropenem
Doxycycline
Gentamicin
CLARITHROMYCIN
TRIMETHOPRIM
Co-trimoxazole
Rifampicin
Isoniazid
Pyrazinamide
Ethambutol
METRONIDAZOLE
Ciprofloxacin
Nitrofurantoin
Clindamycin
Vancomycin
Fluconazole
NYSTATIN
ERYTHROMYCIN
5.3
5.4
Antiviral drugs
Antiprotozoal Drugs
HIV infection
Efavirenz
Tenofovir
Darunavir
Aciclovir
Antimalarials
Quinine
Chloroquine
5.5
Anthelmintics
Piperazine
BNF Section 6 Drugs Used in the Treatment of Disorders of the Endocrine System
6.1
Insulins
Sulphonylureas
Biguanides
Other antidiabetics
Treatment of Hypoglycaemia
6.2
6.3
Corticosteroids
6.4
Sex Hormones
6.5
MAIN DRUGS
INSULIN (soluble)
INSULIN (Isophane)
Insulin Aspart
Insulin Glargine
GLICLAZIDE
METFORMIN
Pioglitazone
Progestogens
Male Sex Hormones
Anti-oestrogens
GLUCOSE 20%
Glucagon
LEVOTHYROXINE
Carbimazole
Fludrocortisone
PREDNISOLONE
HYDROCORTISONE
CONJUGATED
OESTROGENS
NORETHISTERONE
Testosterone
Clomifene citrate
Tetracosactide
Thyroid Hormones
Antithyroid drugs
Replacement therapy
Glucocorticoid therapy
Oestrogens and HRT
Somatropin
(recombinant human
ALTERNATIVES
growth hormone)
6.6
Desmopressin
Bisphosphonates
Alendronic acid
BNF Section 7 Drugs used in Obstetrics, Gynaecology and Urinary Tract Disorders
7.1
7.2
Anti-progestogen
Topical Oestrogens
Fungal infections
7.3
Contraceptives
Intra-Uterine Devices
7.4
BRANDED DRUG*
e.g Prostin E2
e.g Syntometrine
e.g Syntocinon
e.g Microgynon
e.g Cerazette
e.g Depo-Provera
e.g Mirena
Oxybutynin
Sildenafil
*An example of a commonly used brand is provided in this section only as you may encounter these drugs being
prescribed by brand in your clinical attachment.
BNF Section 8 Drugs used in the treatment of Malignant Disease and Immunosuppression
8.1
8.2
8.3
Cytotoxic drugs
Alkylating Agents
Anthracyclines
Antimetabolites
Vinca Alkaloids and Etoposide
MAIN DRUGS
Cyclophosphamide
Doxorubicin
METHOTREXATE
Vincristine
Platinum compounds
Protein kinase inhibitors
Anti-proliferative
immunosupressants
Corticosteroids and other
immunosuppressants
Hormone Antagonists
Cisplatin
Imatinib
Azathioprine
Gonadorelin analogues
Anti-androgens
Leuroprelin
Flutamide
PREDNISOLONE
Ciclosporin
Tamoxifen
9.2
9.5
Minerals
9.6
Vitamins
Calcium supplements
Magnesium
Vitamin B group
Vitamin D
Vitamin K
MAIN DRUGS
FERROUS SULPHATE
FOLIC ACID
HYDROXOCOBALAMIN
Epoietins
POTASSIUM CHLORIDE
SODIUM CHLORIDE
GLUCOSE
Albumin
Calcium salts
Magnesium sulfate
THIAMINE
Alfacalcidol
Colecalciferol
PHYTOMENADIONE
BNF Section 10 Drugs used in the Treatment of Musculoskeletal and Joint Disease
10.1
Non-steroidal anti-inflammatory
drugs (NSAIDs)
Corticosteroids
10.2
MAIN DRUGS
NAPROXEN
Celecoxib
PREDNISOLONE
Methylprednisolone
(intra-articular injection)
METHOTREXATE
Azathioprine
ETANERCEPT
ALLOPURINOL
Pyridostigmine
DIAZEPAM
Baclofen
ALTERNATIVES
IBUPROFEN
Diclofenac
BNF Section 11
11.3
11.4
11.5
11.6
Treatment of Glaucoma
11.8
Miscellaneous Ophthalmic
Preparations
Beta-blockers
Prostagladin analogues and
prostamides
Carbonic anhydrase inhibitors and
systemic drugs
Miotics
Tear Deficiency,ocular lubricants
and astringents
Ocular diagnostic preparations
MAIN DRUGS
CHLORAMPHENICOL
PREDNISOLONE
Tropicamide
Atropine
Timolol
Latanoprost
Dorzolamide
Pilocarpine
Hypromellose
Fluorescein sodium
ALTERNATIVES
BETAMETHASONE
BNF Section 12 Drugs used in the treatment of the Ear Nose and Oropharynx
12.1
Otitis externa
12.2
12.3
MAIN DRUGS
ALTERNATIVES
BETAMETASONE ear drops
Gentamicin ear drops
Gentamicin and
hydrocortisone ear drops
BECLOMETASONE nasal
spray
Benzydamine
hydrochloride
NYSTATIN
BNF Section 13
13.2
13.4
13.5
13.6
13.10
Antibacterial preparations
Antifungal preparations
Antiviral preparations
Parasiticidal preparations
MAIN DRUGS
Aqueous cream
Epaderm
BETAMETHASONE
HYDROCORTISONE
Coal Tar
Dithranol
Calcipotriol
Methotrexate
Azathioprine
Ciclosporin
Etanercept
Benzoyl peroxide
Oxytetracycline
Isotretinoin
Mupirocin
Clotrimazole
Aciclovir
Permethrin
ALTERNATIVES
BNF Section 14
14.4
14.5
Immunoglobulins
Diptheria, Tetanus,
Pertussis (Acellular
component), Poliomyelitis
(Inactivated) and
Haemophilus Influenza
type b Vaccine (Hib)
Measles Mumps &
Rubella, Live (MMR)
Vaccine
Meningococcal Group C
conjugate Vaccine
Pneumococcal
Polysaccharide conjugate
vaccine
Human Papilloma Virus
(HPV) vaccine
Rotavirus vaccine
BCG vaccine
Hepatitis A Vaccine
Hepatitis B Vaccine
Influenza Vaccine
Shingles vaccine
Anti-D(Rho)
Immunoglobulin
BNF Section 15
15.1
General Anaesthesia
15.2
Local Anaesthesia
MAIN DRUGS
Propofol
Thiopental sodium
Isoflurane
Nitrous oxide
ATROPINE
Atracurium
Suxamethonium
Flumazenil
NALOXONE
LIDOCAINE
Prevention of absorption
Paracetamol
MAIN DRUGS
ACTIVATED CHARCOAL
ACETYLCYSTEINE
Opioid
Iron
NALOXONE
Desferrioxamine
Organophosphates
ATROPINE
Pralidoxime
Acknowledgements:
Formulary originally devised by Prof Simon Thomas and Dr Ruben Thanacoody, Institute of Cellular Medicine, Newcastle University. Edited by
Dr Guilding and Dr Ball, School of Medical Education.